1. Hormonal control of mRNA expression of immunoglobulin binding factor in uterine cervix.
- Author
-
Yoshikawa S, Kamada M, Maegawa M, Yamamoto S, Irahara M, Yamano S, Aono T, Kido H, and Koide SS
- Subjects
- Animals, Estradiol blood, Female, Humans, In Situ Hybridization, Lymphokines biosynthesis, Progesterone blood, Protein Disulfide-Isomerases biosynthesis, Protein Disulfide-Isomerases genetics, RNA, Messenger biosynthesis, Rats, Reverse Transcriptase Polymerase Chain Reaction, Tumor Cells, Cultured, Cervix Uteri physiology, Estradiol physiology, Gene Expression Regulation, Lymphokines genetics, Progesterone physiology, Prostatic Secretory Proteins
- Abstract
Uterine cervical mucus contains an immunoglobulin binding factor (IgBF). It may play a role in preventing antibody production against sperm in the female reproductive tract. To elucidate the mechanism involved in the production of activated IgBF, we determined the effects of hormones on the expression of mRNAs of IgBF and of protein disulfide isomerase (PDI), activating enzyme, in uterine cervix by quantitative RT-PCR. The uterine cervices of female rats were excised at preovulatory, ovulatory, and postovulatory phases. The human uterine cervical adenocarcinoma cells (TCO-2) were cultured for 24 h in serum-free medium containing 17beta-estradiol or progesterone. Expression of IgBF and PDI mRNAs was significantly highest during the ovulatory phase. 17beta-estradiol stimulated the expression of both mRNAs in TCO-2; whereas progesterone was ineffective. In conclusion, estrogen regulates the production of IgBF by the endocervix and PDI in vivo, thereby increasing the level of activated IgBF in the female reproductive tract during the ovulatory phase, allowing sperm to enter the uterine cavity.
- Published
- 2000
- Full Text
- View/download PDF